الصفحة الرئيسية>>Peptides>>MPG, HIV related

MPG, HIV related

رقم الكتالوجGC32316

MPG ، HIV المرتبط بـ 27-aa peptide ، مشتق من كل من تسلسل التوطين النووي لمستضد SV40 كبير T ومجال ببتيد الاندماج لـ HIV-1 gp41 وهو عامل توصيل فعال للتوصيل العام للأحماض النووية وأوليغنوكليوتيدات إلى المستنبتات الخلايا

Products are for research use only. Not for human use. We do not sell to patients.

MPG, HIV related التركيب الكيميائي

Cas No.: 395069-92-8

الحجم السعر المخزون الكميّة
1mg
202٫00
متوفر
5mg
597٫00
متوفر
10mg
873٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MPG, HIV related is 27-aa peptide, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells.

MPG, HIV related is 27-aa peptide vector, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells and for gene therapy. MPG enables complete expression of the gene produces encoded by the plasmids it delivers into cultured cell[1].

[1]. Morris MC, et al. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res. 1999 Sep 1;27(17):3510-7.

مراجعات

Review for MPG, HIV related

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MPG, HIV related

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.